Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Feb;60(2):675-82.
doi: 10.1128/iai.60.2.675-682.1992.

Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development

Affiliations

Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development

D L Doolan et al. Infect Immun. 1992 Feb.

Abstract

The design of a subunit vaccine against the malaria parasite relies on the epitopes recognized by T cells being identified and polymorphisms therein being defined. Here we present the analysis of a 354-bp fragment of the circumsporozoite (CS) protein encompassing defined proliferative and cytotoxic T-cell recognition regions. We reveal that the polymorphism of CS protein T-cell sites appears to be very limited among Plasmodium falciparum isolates prevalent in certain geographical regions, in particular Papua New Guinea. Furthermore, the more extensive polymorphism noted in other areas appears to be restricted. Although the extent of variation observed for the T-cell recognition domains suggests that any vaccine designed to stimulate this form of immunity will need to be polyvalent, this variation appears to be finite and the combination of peptides necessary for inclusion in a polyvalent vaccine may be small. If ways to increase immune responsiveness can be found, then a vaccine designed to stimulate CS protein-specific T-cell activity may prevent malaria.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Immunol Lett. 1990 Aug;25(1-3):23-6 - PubMed
    1. J Immunol. 1989 May 15;142(10):3568-75 - PubMed
    1. Int Immunol. 1991 Jun;3(6):579-85 - PubMed
    1. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3300-4 - PubMed
    1. Int Immunol. 1990;2(10):945-55 - PubMed

Publication types

MeSH terms